COMMUNIQUÉS West-GlobeNewswire

Jounce Therapeutics Founder Dr. James P. Allison Jointly Awarded 2018 Nobel Prize in Physiology or Medicine for the Discovery of Cancer Therapy by Inhibition of Negative Immune Regulation
01/10/2018
CAMBRIDGE, Mass., Oct. 01, 2018 (GLOBE NEWSWIRE) -- Jounce Therapeutics, Inc. (NASDAQ: JNCE), a clinical-stage company focused on the discovery and development of novel cancer immunotherapies and predictive biomarkers, [...]
Easton Pharmaceuticals Is Short-Listed to Acquire an Interest in an Operating Casino and Hotel Resort in Loutraki, Greece with Revenues in Excess of 60 Million Euro Per Year
01/10/2018
TORONTO, ON, Oct. 01, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Easton Pharmaceuticals Inc. (OTC: EAPH ) announces that it has made it to the short-list to acquire an interest or participate in the acquisition of [...]
GUERBET : Information sur les opération effectuées dans le cadre du programme de rachat d'actions
01/10/2018
Villepinte (France), le 01 octobre 2018 Le présent document a pour finalité de présenter les opérations réalisées dans le cadre du programme de rachat d'actions autorisé par l'Assemblée Générale Mixte du 25 mai 2018 sur [...]
BioStem Life Sciences, Inc., Subsidiary of BioStem Technologies, Inc., Announces Entry into Market with Four Amniotic Products
01/10/2018
Pompano Beach, FL, Oct. 01, 2018 (GLOBE NEWSWIRE) -- BioStem Life Sciences (“Life Sciences” or the “Company”), a wholly owned subsidiary of BioStem Technologies, Inc. (OTC PINK: BSEM), a Company focused on the [...]
Statement by Irina Maligina, Member of the Supervisory Council at JSC Olainfarm: "In close cooperation with the Board of directors, we have resumed work on the development of the company and this should be continued"
01/10/2018
The new Supervisory Council of JSC Olainfarm in cooperation with the company's Board has resumed the implementation of the company's development and growth plan in order to realize Valery Maligin's vision of Olainfarm [...]
EHNAC Releases New 2019 Accreditation Criteria Versions for Public Review Through Dec. 6
01/10/2018
Most significant criteria changes to the organization’s accreditation programs includes incorporation of GDPR and New York State Cybersecurity Requirements FARMINGTON, Conn., Oct. 01, 2018 (GLOBE NEWSWIRE) -- The [...]
Bio-on board of directors approves six-monthly consolidated report of 30 June 2018
01/10/2018
Bologna (Italy) , 1 st october 2018 – Bio-On S.p.A., listed on the AIM segment of Borsa Italiana and operating in the sector of PHAs bioplastics and the new green chemical industry, announces that its board of directors [...]
Immunicum AB (publ) Gives Information on Trading Halt and Ongoing Negotiations for a Potential Collaboration
01/10/2018
Press Release 1 October 2018 Immunicum AB (publ) Gives Information on Trading Halt and Ongoing Negotiations for a Potential Collaboration Immunicum AB (publ; IMMU.ST) today announced that Nasdaq Stockholm decided to [...]
Block listing Interim Review
01/10/2018
BLOCK LISTING SIX MONTHLY RETURN (Note: Italicised terms have the same meaning as given in the Listing Rules.) Date: 01 October 2018 Name of applicant : Summit Therapeutics plc Name of scheme: 2005 EMI Scheme Period of [...]
Microbot Medical Inc. to Present at the Ladenburg Thalmann Healthcare Conference
01/10/2018
HINGHAM, Mass., Oct. 01, 2018 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq CM: MBOT), a medical device company specializing in the design and development of transformational micro-robotic medical technologies, [...]
TRHC’s Capstone Performance System Continues Growth
01/10/2018
All Service Lines Won New Contracts or Expanded Services to Existing Clients ST. LOUIS and MOORESTOWN, N.J., Oct. 01, 2018 (GLOBE NEWSWIRE) -- Tabula Rasa HealthCare, Inc. (“TRHC”) (NASDAQ:TRHC), a healthcare technology [...]
Neon Therapeutics Congratulates Founder James P. Allison, Ph.D., for 2018 Nobel Prize in Physiology or Medicine
01/10/2018
Award Recognizes Achievements in Cancer Immunotherapy CAMBRIDGE, Mass., Oct. 01, 2018 (GLOBE NEWSWIRE) -- Neon Therapeutics, Inc. (Nasdaq: NTGN), a clinical-stage immuno-oncology company developing neoantigen-based [...]
Wildflower Signs MOU to Enter LA Delivery Market
01/10/2018
VANCOUVER, British Columbia, Oct. 01, 2018 (GLOBE NEWSWIRE) -- Wildflower Brands Inc. (CSE: SUN , OTC: WLDFF ) (the “ Company ”), is excited to announce that they have received a Memorandum of Understanding (MOU) with [...]
Keryx Biopharmaceuticals Announces Participation in an Upcoming Investor Conference
01/10/2018
BOSTON, Oct. 01, 2018 (GLOBE NEWSWIRE) -- Keryx Biopharmaceuticals, Inc. (Nasdaq:KERX), a biopharmaceutical company focused on bringing innovative medicines to people with kidney disease, today announced that it will [...]
UPDATE: Nephros Announces Preliminary Financial Results for Third Quarter 2018
01/10/2018
Anticipates 102% Year-over-Year Product Revenue Growth; Reiterates $6 Million 2018 Revenue Target SOUTH ORANGE, NJ, Oct. 01, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Nephros, Inc. (OTCQB: NEPH), a commercial stage [...]
Altasciences Completes Acquisition of Preclinical Testing Business and Hires Key Staff
01/10/2018
LAVAL, Québec, Oct. 01, 2018 (GLOBE NEWSWIRE) -- Altasciences today announced the completion of the acquisition of a preclinical testing business in Everett, Washington. This transaction will support Altasciences’ goal [...]
Altasciences complète l’acquisition des activités d’essais précliniques et embauche du personnel clé
01/10/2018
LAVAL, Québec, 01 oct. 2018 (GLOBE NEWSWIRE) -- Altasciences a annoncé aujourd’hui l’acquisition des activités d’essais précliniques d’une installation située à Everett, dans l’État de Washington. Cette transaction s’ [...]
Cantabio Pharmaceuticals to Present Latest Positive In Vivo Results From its DJ-1 Targeting Small Molecule Drug Development Program for Parkinson’s Disease at the Milner Therapeutics Symposium at the University of Cambridge, UK
01/10/2018
SAN FRANCISCO, Oct. 01, 2018 (GLOBE NEWSWIRE) -- Cantabio Pharmaceuticals Inc. (OTCQB: CTBO), a biopharmaceutical company developing novel disease modifying therapies for Alzheimer's (AD), Parkinson's (PD) and other [...]
Nova Leap Health Corp. Completes Purchase of Third Massachusetts Home Care Business
01/10/2018
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES HALIFAX, Nova Scotia, Oct. 01, 2018 (GLOBE NEWSWIRE) -- NOVA LEAP HEALTH CORP. (TSXV: NLH) ("Nova Leap" or “the Company”), a [...]

Pages